About Torigen
Torigen is a company based in Farmington (United States) founded in 2012.. Torigen has raised $20.82 million across 6 funding rounds from investors including Notre Dame, Connecticut Innovations and Werth Ventures. The company has 16 employees as of December 31, 2024. Torigen operates in a competitive market with competitors including LEAH Labs, AlsterScience, Narval, Jenga Biosciences and Hastim, among others.
- Headquarter Farmington, United States
- Employees 16 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Torigen Pharmaceuticals, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20.82 M (USD)
in 6 rounds
-
Latest Funding Round
$13 M (USD), Series A
Nov 16, 2022
-
Investors
Notre Dame
& 11 more
-
Employee Count
16
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Torigen
Torigen has successfully raised a total of $20.82M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $13 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $13.0M
- First Round First Round
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Series A - Torigen | Valuation | Connecticut Innovations , Werth Ventures | |
| Dec, 2021 | Amount | Series A - Torigen | Valuation |
investors |
|
| Mar, 2021 | Amount | Series A - Torigen | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Torigen
Torigen has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Notre Dame, Connecticut Innovations and Werth Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investing with a focus on diversity and inclusion in the ecosystem.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Torigen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Torigen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Torigen Comparisons
Competitors of Torigen
Torigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as LEAH Labs, AlsterScience, Narval, Jenga Biosciences and Hastim, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene-editing tools for canine cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Provider of immunotherapies for animals
|
|
| domain | founded_year | HQ Location |
Monoclonal antibody therapeutics are developed for multiple diseases.
|
|
| domain | founded_year | HQ Location |
Develops oncology treatments for pets by identifying breakthroughs and navigating trials.
|
|
| domain | founded_year | HQ Location |
Develops cancer immunotherapy kits for veterinary and human health applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Torigen
Frequently Asked Questions about Torigen
When was Torigen founded?
Torigen was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Where is Torigen located?
Torigen is headquartered in Farmington, United States.
Is Torigen a funded company?
Torigen is a funded company, having raised a total of $20.82M across 6 funding rounds to date. The company's 1st funding round was a Series A of $3.5M, raised on Jun 01, 2017.
How many employees does Torigen have?
As of Dec 31, 2024, the latest employee count at Torigen is 16.
What does Torigen do?
Torigen was founded in 2012 in Farmington, United States, and operates in the veterinary biotechnology sector. Autologous cancer vaccines are developed by the company for treating animal cancers. VetiVax, a key product, is created using a patients own tumor cells to train the immune system against tumors. Services focus on personalized immunotherapies tailored to individual veterinary cases.
Who are the top competitors of Torigen?
Torigen's top competitors include LEAH Labs, AlsterScience and Narval.
Who are Torigen's investors?
Torigen has 12 investors. Key investors include Notre Dame, Connecticut Innovations, Werth Ventures, Gaingels, and Emerald.